- What is OrSense's primary focus?
- OrSense is a medical device company specializing in the development and commercialization of noninvasive monitoring technologies for continuous and spot measurements of blood parameters such as hemoglobin, oxygen saturation, and glucose.
- Where is OrSense headquartered?
- OrSense is headquartered in Petah Tikva, Center District, Israel, with an additional office in Raleigh, United States.
- What is OrSense's core technology?
- OrSense utilizes its patented SpectOLight technology, also known as occlusion spectroscopy. This technology employs a non-invasive optical measurement platform with a finger-attached, ring-shaped sensor probe to create unique blood dynamics for sensitive measurement of blood parameters.
- When was OrSense founded?
- OrSense was founded in October 1996.
- What is the total amount of funding OrSense has raised to date?
- OrSense has raised a total of $44,400,000 in funding.
- When was OrSense's last known funding round and how much was raised?
- OrSense's last known funding round occurred in May 2011, raising $18,000,000.
- Which investors participated in OrSense's August 2001 funding round?
- In August 2001, OrSense received funding from Israel HealthCare Ventures and Star Ventures.
- Which investors participated in OrSense's February 2006 funding round?
- In February 2006, OrSense received funding from Lewis Trust Group and Israel HealthCare Ventures.
- Who are the key executives at OrSense?
- The key executives at OrSense include Yoav Reisman as CEO, Guy Greitser as VP BD, and Efi Gabis as VP Operations.